Literature DB >> 18823980

Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.

Fabiane Matos Dos Santos1, Sérgio Caldas, Stêfany Bruno de Assis Cáu, Geovam Pereira Crepalde, Marta de Lana, George L L Machado-Coelho, Vanja Maria Veloso, Maria Terezinha Bahia.   

Abstract

Through a continuous in vivo drug pressure protocol, using mice as experimental model, we induced benznidazole resistance in Trypanosoma cruzi stocks. Full resistance was obtained for four out of five T. cruzi stocks analyzed. However, the number of benznidazole doses (40-180), as well as the time (4-18 months) necessary to induce resistance varied among the different T. cruzi stocks. The resistance phenotype remained stable after T. cruzi stocks has been maintained by 12 passages in mice (six months) and in acellular culture for the same time. However, the maintenance of resistant parasite for 12 months in acellular culture induces a reduction in its level of benznidazole resistance, while no alteration was detected in parasite maintained for the same time in mice. The data showed the stability of the resistance acquired by drug pressure, but suggest the possibility of reversible changes in the resistance levels after maintenance for long time in acellular culture.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18823980     DOI: 10.1016/j.exppara.2008.09.007

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  13 in total

1.  Hydroxymethylnitrofurazone treatment in indeterminate form of chronic Chagas disease: Reduced intensity of tissue parasitism and inflammation-A histopathological study.

Authors:  Cauê B Scarim; Cleverton R de Andrade; João A da Rosa; Jean L Dos Santos; Chung M Chin
Journal:  Int J Exp Pathol       Date:  2018-10-15       Impact factor: 1.925

2.  New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice.

Authors:  Juan M Bustamante; Julie M Craft; Byron D Crowe; Sarah A Ketchie; Rick L Tarleton
Journal:  J Infect Dis       Date:  2013-08-14       Impact factor: 5.226

3.  Therapy of chagas disease: implications for levels of prevention.

Authors:  Sergio Sosa-Estani; Lisandro Colantonio; Elsa Leonor Segura
Journal:  J Trop Med       Date:  2012-03-05

4.  Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly Sensitive In Vivo Imaging.

Authors:  Amanda Fortes Francisco; Michael D Lewis; Shiromani Jayawardhana; Martin C Taylor; Eric Chatelain; John M Kelly
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

Review 5.  Translational challenges of animal models in Chagas disease drug development: a review.

Authors:  Eric Chatelain; Nandini Konar
Journal:  Drug Des Devel Ther       Date:  2015-08-19       Impact factor: 4.162

6.  Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.

Authors:  Ágata Carolina Cevey; Gerardo Ariel Mirkin; Federico Nicolás Penas; Nora Beatriz Goren
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2015-12-12       Impact factor: 4.077

7.  Up-regulation of ATP-binding cassette transporters in the THP-1 human macrophage cell line by the antichagasic benznidazole.

Authors:  Virginia G Perdomo; Juan P Rigalli; Marcelo G Luquita; José M Pellegrino; María Laura Ruiz; Viviana A Catania
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-10-24       Impact factor: 2.743

8.  Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.

Authors:  Marcela S Rial; María L Scalise; Eva C Arrúa; Mónica I Esteva; Claudio J Salomon; Laura E Fichera
Journal:  PLoS Negl Trop Dis       Date:  2017-12-21

9.  Evolution of resistance to single and combined floral phytochemicals by a bumble bee parasite.

Authors:  E C Palmer-Young; B M Sadd; L S Adler
Journal:  J Evol Biol       Date:  2016-11-23       Impact factor: 2.411

10.  P-glycoprotein efflux pump plays an important role in Trypanosoma cruzi drug resistance.

Authors:  Mônica Caroline Oliveira Campos; Denise Barçante Castro-Pinto; Grazielle Alves Ribeiro; Márcia Moreira Berredo-Pinho; Leonardo Henrique Ferreira Gomes; Myrtes Santos da Silva Bellieny; Carla Marins Goulart; Aurea Echevarria; Leonor Laura Leon
Journal:  Parasitol Res       Date:  2013-04-10       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.